In addition, SOCS3 has previously been reported to be hypermethylated in melanoma (Tokita et al., 2007), while loss of RAC3 expression has been associated with impaired invasion in glioma and breast carcinoma cells (Chan et al., 2005; Baugher et al., 2005). This evidence concerns the gene RAC3 and melanoma.